Companies in the neuroscience sector developing innovative solutions and technologies.
Explore 339 recently funded neuroscience companies with verified founder contact information and fundraising data.
Sora Neuroscience is a healthcare company that incorporates neuroscience into clinical practice.
Axonis Therapeutics is a neuro-focused biotechnology company that focuses on the development of novel neuromedicines.
Symbionics is a brain-computer interface company that focuses on the development of interface devices to integrate humans and machines.
Resolve Biosciences is a biotechnology research company for molecular cartography.
Verge Genomics uses machine learning and human genomics to accelerate drug discovery.
Cleveland Diagnostics is a diagnostics company developing efficacious, affordable diagnostics tests to improve cancer diagnostics.
clear_pixel VR accelerates critical skill uptake in biomedical and pharmaceutical laboratories through VR training.
Empyrean is using genetic engineering to treat severe neuropsychiatric and neurologic illnesses in a way that will revolutionize healthcare.
AtaiBeckley develops innovative mental health treatments that address significant unmet medical needs.
Soterix Medical develops devices and accessories based on neuromodulation and brain stimulation technologies.
Braingrade developing a new solution for patients with Alzheimer’s Disease.
Media measurement solution to measure the emotional impact their content has on consumers to optimize advertising and content decisions
Entheos Labs advances psychedelic medicines to treat mental health conditions like schizophrenia and Alzheimer's disease.
The neuroscience sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.
Neuroscience companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.
The neuroscience sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.
Here is how funding is distributed among the 339 neuroscience companies tracked in the VCBacked database.
Companies in the neuroscience sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.
Perfect for: B2B sales teams targeting neuroscience companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked